AI and a smartphone app may let kids with asthma skip clinic visits

NCT ID NCT06062433

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether children aged 6 to 17 with asthma can manage their condition remotely using an artificial intelligence tool called the Asthma-Guidance and Prediction System, combined with a home monitoring device (AsthmaTuner). The goal is to see if this approach improves satisfaction with asthma care compared to usual clinic visits. Researchers will also measure how much time clinicians save in preparing for appointments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an AI-assisted clinical decision support system (Asthma-Guidance and Prediction System) paired with a home monitoring device (AsthmaTuner, a phone app and spirometer)
What this could lead to
If it works, this could point toward a more convenient, effective way for children with asthma to manage their condition from home, reducing clinic visits.
What could go wrong
This is a small, early feasibility trial with only 49 participants, so results may not apply broadly. The system relies on technology and patient engagement, which may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.